V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Neogen Executive Compensation (FY26)

NEOG · Executive and director compensation, fiscal 2022 to 2026
Chief executive, fiscal 2026
◇
Mike Nassif
Latest say-on-pay support
=
October 1, 2026
Velarion Member: every covered company in one industry, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Neogen

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
Data as of October 18, 2026Latest filing (8-K): October 7, 2026
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Neogen brief$1,500Get the executive brief
Velarion Member, one year
239 figures on this page: 228 cited to the filing that reported them, 11 calculated from figures it prints. See the citations

More on Neogen

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2025 to fiscal 2026
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: John Adent → Mike Nassif
Say-on-pay support: 90.4% → 98.4% (8.0 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Neogen's chief executive and what were they paid?
Mike Nassif was paid $8,693,916 in total compensation as President & Chief Executive Officer for fiscal 2026.
What was Neogen's say-on-pay result?
Shareholders supported the say-on-pay proposal with 98.4% of votes cast for or against in favor at the meeting held October 1, 2026 for fiscal 2026.
Which companies are in Neogen's peer group?
The disclosed peer group names 10x Genomics, Inc., Azenta, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation and Bruker Corporation, among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Adent
President & Chief Executive Officer
◇—◇◇◇—◇◇
Douglas Jones
Chief Operating Officer
◇—◇◇◇—◇◇
Amy Rocklin
Chief Legal & Compliance Officer
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Adent
President & Chief Executive Officer
◇—◇◇◇—◇◇
David Naemura
Chief Financial Officer
◇—◇◇◇—◇◇
Douglas Jones
Chief Operating Officer
◇—◇◇◇—◇◇
Amy Rocklin
Chief Legal & Compliance Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Adent
President & Chief Executive Officer
◇—◇◇◇—◇◇
David Naemura
Chief Financial Officer
◇—◇◇◇—◇◇
Douglas Jones
Chief Operating Officer
◇—◇◇◇—◇◇
Amy Rocklin
Chief Legal & Compliance Officer
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Adent
President & Chief Executive Officer
◇—◇◇——◇◇
David Naemura
Chief Financial Officer & Chief Operating Officer
◇—◇◇——◇◇
Douglas Jones
Chief Operating Officer (Retired)
Departed during or after this year
◇—◇◇——◇◇
Amy Rocklin
Chief Legal & Compliance Officer
◇—◇◇——◇◇
Fiscal 2026
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mike Nassif
President & Chief Executive Officer
◇◇◇◇◇—◇◇
R. Bryan Riggsbee
Senior Vice President
◇◇◇◇◇—◇◇
Tamara Ranalli
Senior Vice President and General Manager, Global Food Safety
◇◇◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Amy M. RocklinOPTION◇——◇—◇◇
David H. NaemuraOPTION◇——◇—◇◇
David H. NaemuraOPTION◇——◇—◇◇
Douglas E. JonesOPTION◇——◇—◇◇
John E. AdentOPTION◇——◇—◇◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2026 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
John AdentOption◇—◇5/25/2027
Option◇—◇10/31/2028
Option◇—◇10/31/2028
Option◇—◇10/31/2028
Amy RocklinOption◇—◇6/29/2026
Option◇—◇6/29/2026
Option◇—◇6/29/2026
Option◇—◇6/29/2026
Option◇—◇6/29/2026
Option◇—◇6/29/2026
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2026
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Andrea F. Wainer
◇◇◇———◇
James C. Borel
Board chair
◇◇◇———◇
Jeffrey D. Capello
◇◇◇———◇
Thierry L. Bernard
◇◇◇———◇
Ronald D. Green, Ph.D
◇◇◇———◇
Catherine E. Woteki, Ph.D
◇◇◇———◇
Raphael A. Rodriguez
◇◇◇———◇
Aashima Gupta
◇◇◇———◇
Avi Pelossof
◇◇◇———◇
William T. Boehm, Ph.D
◇—————◇
Mike Nassif served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as Rsus/Options.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2026
  • 10x Genomics, Inc. TXG
  • Azenta, Inc. AZTA
  • Bio-Rad Laboratories, Inc. BIO
  • Bio-Techne Corporation TECH
  • Bruker Corporation BRKR
  • Charles River Laboratories International, Inc. CRL
  • Exact Sciences Corporation EXAS
  • Guardant Health, Inc. GH
  • IDEXX Laboratories, Inc. IDXX
  • iRhythm Technologies, Inc. IRTC
  • Maravai LifeSciences Holdings, Inc. MRVI
  • Mettler-Toledo International, Inc. MTD
  • Natera, Inc. NTRA
  • NeoGenomics, Inc. NEO
  • OraSure Technologies, Inc. OSUR
  • QuidelOrtho Corporation QDEL
  • Repligen Corporation RGEN
  • Sotera Health Company SHC
  • Waters Corporation WAT

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2026October 1, 2026=◇◇◇
2025October 23, 2025=◇◇◇
2024October 24, 2024=◇◇◇
2023October 25, 2023=◇◇◇
2022October 6, 2022=◇◇◇
2021October 7, 2021=◇◇◇
2020October 8, 2020=◇◇◇
2019October 3, 2019=◇◇◇
2018October 4, 2018=◇◇◇
2017October 5, 2017=◇◇◇
2016October 6, 2016=◇◇◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Mike Nassif (President & Chief Executive Officer), FY2026 total compensation $8,693,916 (base salary $630,769) [exec_comp, SEC accession 0001193125-26-360742, filed 2026-08-21]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when Neogen files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Neogen disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Neogen sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Neogen's disclosed peer group is defensible, who names Neogen back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
239 figures on this page: 228 cited to the filing that reported them, 11 calculated from figures it prints.
228 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001193125-26-416247
    Proposal 2 – To Approve, on an Advisory Basis, the Compensation of the Company’s Named Executive Officers The shareholders approved, on an advisory basis, the compensation of the Company’s named execu
  2. 0001193125-26-360742
    Compensation of Directors
  3. 0001193125-25-250823
    Proposal 2 – To Approve, by Non-Binding Vote, the Compensation of the Company’s Named Executive Officers The shareholders did not approve, by non-binding vote, the compensation of the Company’s named
  4. 0000950170-25-114381
    Summary Compensation Table
  5. 0000950170-24-117710
  6. 0000950170-24-106219
  7. 0000950170-23-056922
  8. 0001193125-22-259702
  9. 0001193125-21-295527
  10. 0001193125-20-267250
  11. 0001193125-19-263834
  12. 0001193125-18-294770
  13. 0001193125-17-306007
  14. 0001193125-16-733591
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Neogen executive compensation, FY2022–FY2026.” https://intel.velarion.ai/comp/NEOG (accessed 2026).
Short form: data: Velarion

The paid brief for Neogen

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Neogen and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Neogen discloses

The companies named in NEOG's own disclosed peer group.

10x Genomics, Inc.Azenta, Inc.Bio-Rad Laboratories, Inc.Bio-Techne CorporationBruker CorporationCharles River Laboratories International, Inc.Exact Sciences CorporationGuardant Health, Inc.IDEXX Laboratories, Inc.iRhythm Technologies, Inc.Maravai LifeSciences Holdings, Inc.Mettler-Toledo International, Inc.Natera, Inc.NeoGenomics, Inc.OraSure Technologies, Inc.QuidelOrtho CorporationRepligen CorporationSotera Health CompanyWaters Corporation

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy